Shopping Cart
- Remove All
Your shopping cart is currently empty
Integrin Antagonists 27, a small molecule integrin αvβ3 antagonist with a binding affinity of 18 nM, serves as a novel anticancer agent.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $198 | 8-10 weeks | |
| 5 mg | $347 | 8-10 weeks | |
| 25 mg | $1,140 | 8-10 weeks | |
| 50 mg | $1,490 | 8-10 weeks | |
| 100 mg | $1,990 | 8-10 weeks | |
| 1 mL x 10 mM (in DMSO) | $382 | 8-10 weeks |
| Description | Integrin Antagonists 27, a small molecule integrin αvβ3 antagonist with a binding affinity of 18 nM, serves as a novel anticancer agent. |
| In vitro | Integrin Antagonists 27 is treated with a panel of cancer cell lines. Which include breast cancer cell line MDA-MB-435, breast cancer cell lines MCF-7, mouse fibroblast NIH3T3, ovarian cancer cell line HEY, lung cancer cell line NCI-H1975. It has an IC50 of >20 uM. |
| Molecular Weight | 444.44 |
| Formula | C24H20N4O5 |
| Cas No. | 593274-97-6 |
| Relative Density. | 1.38 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (225 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.